Kamal Shah

Targeted Therapeutics in Breast Cancer: Promise, Progress, and the Challenge of Triple-negative Subtype.

INTRODUCTION Breast cancer is the most common cancer that affects women globally, with several molecular subtypes defined by hormone and growth factor receptor expression. While advances in understanding the biology of these subtypes have led to targeted therapies, aggressive forms, particularly Triple-Negative Breast...